Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy

Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy

Abstract Background Treatment of recurrent nasopharyngeal carcinoma is a challenging clinical problem. We report the case of a 46 year old male showing excellent response and signs of immunostimulation following re-re-irradiation for recurrent nasopharyngeal carcinoma under systemic treatment with p...

Full description

Bibliographic Details
Main Authors: T. Finazzi, T. Rordorf, K. Ikenberg, G. F. Huber, M. Guckenberger, H. I. Garcia Schueler
Format: Article
Language:English
Published: BMC 2018-04-01
Series:BMC Cancer
Subjects:
Nasopharyngeal
Radiotherapy, immunotherapy
Immunostimulation
Pembrolizumab
Online Access:http://link.springer.com/article/10.1186/s12885-018-4295-8

Internet

http://link.springer.com/article/10.1186/s12885-018-4295-8

Similar Items